Document is current
Any future updates will be listed below
-
Authors
Asare, Matthew
Sam-Agudu, Nadia Adjoa
Cudjoe, Obed
Frueh, Emily
Coker, Karen Awura-Adjoa Ronke
Dankyi, Alex Boadi
Ken-Amoah, Sebastian
Akakpo, Patrick Kafui
Enyan, Nancy Innocentia Ebu
Sturdivant, Rodney X.
Asmah, Emmanuel Ekow
Nuer-Allornuvor, Gloria F.
Obiri-Yeboah, Dorcas
-
Funding
Funding for this research was provided by:
National Institute of Health and National Cancer Institute, United States
National Institute of Health and National Cancer Institute,, United States
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 28 January 2026
First Online: 27 March 2026
Declarations
:
: The trial was approved by the Institutional Review Board (IRB) of Baylor University (Ref# 2217862), Ghana Health Service (Ref# GHS-ERC 015/09/24) and Cape Coast Teaching Hospital (Ref# CCTHERC/EC/2024/138). All eligible participants are enrolled under a waiver of informed consent to minimize participation bias. Participants will sign an informed consent form before participating in the study. The study protocol was approved by the Institutional Review Boards (IRBs) of Baylor University and Cape Coast Teaching Hospital to ensure ethical compliance. Cape Coast Teaching Hospital administrators also granted approval to conduct the study at their facility.The trial is registered on ClinicalTrials.gov (NCT06800664), providing public access to key study details. The trial follows the established Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist for accurate documentation and dissemination of findings. The SPIRIT checklist for RCT reporting is included in Additional File 1. Protocol amendments will be submitted for review and approval by the IRBs. If relevant, approved modifications are updated in the trial registry.
: Not applicable.
: The authors declare no competing interests.
